Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation

Erhan Ergene, Pamela K. Behr, Jerry J. Shih

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Vagus nerve stimulation (VNS) is a novel therapy used in patients with medically intractable epilepsy. We administered a Quality of Life in Epilepsy - 10 (QOLIE-10) questionnaire consisting of questions designed to assess the patients' rating of their memory, level of physical and mental well-being, energy, depression, worries about seizures and work, social limitations, and overall quality of life on VNS treatment. The questionnaire was administered before and at 1-3 weeks, 5-7 weeks, 3 months, 6 months, and 9-12 months after the initiation of VNS in 17 patients. QOLIE-10 scores were significantly better after the initiation of the therapy as compared with baseline (P < 0.01). There was no correlation between the improvement in QOLIE-10 scores and the reduction in seizure frequency, decreased severity of seizures, or increased level of energy/alertness. We conclude that VNS therapy is associated with a significant improvement in subjective quality of life.

Original languageEnglish (US)
Pages (from-to)284-287
Number of pages4
JournalEpilepsy and Behavior
Volume2
Issue number3
DOIs
StatePublished - Jun 2001
Externally publishedYes

Fingerprint

Vagus Nerve Stimulation
Quality of Life
Epilepsy
Seizures
Therapeutics
Depression

Keywords

  • Vagus nerve stimulation; quality of life; refractory epilepsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation. / Ergene, Erhan; Behr, Pamela K.; Shih, Jerry J.

In: Epilepsy and Behavior, Vol. 2, No. 3, 06.2001, p. 284-287.

Research output: Contribution to journalArticle

Ergene, Erhan ; Behr, Pamela K. ; Shih, Jerry J. / Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation. In: Epilepsy and Behavior. 2001 ; Vol. 2, No. 3. pp. 284-287.
@article{7067fbd093b24d0986aa3e21b53edea0,
title = "Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation",
abstract = "Vagus nerve stimulation (VNS) is a novel therapy used in patients with medically intractable epilepsy. We administered a Quality of Life in Epilepsy - 10 (QOLIE-10) questionnaire consisting of questions designed to assess the patients' rating of their memory, level of physical and mental well-being, energy, depression, worries about seizures and work, social limitations, and overall quality of life on VNS treatment. The questionnaire was administered before and at 1-3 weeks, 5-7 weeks, 3 months, 6 months, and 9-12 months after the initiation of VNS in 17 patients. QOLIE-10 scores were significantly better after the initiation of the therapy as compared with baseline (P < 0.01). There was no correlation between the improvement in QOLIE-10 scores and the reduction in seizure frequency, decreased severity of seizures, or increased level of energy/alertness. We conclude that VNS therapy is associated with a significant improvement in subjective quality of life.",
keywords = "Vagus nerve stimulation; quality of life; refractory epilepsy",
author = "Erhan Ergene and Behr, {Pamela K.} and Shih, {Jerry J.}",
year = "2001",
month = "6",
doi = "10.1006/ebeh.2001.0173",
language = "English (US)",
volume = "2",
pages = "284--287",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation

AU - Ergene, Erhan

AU - Behr, Pamela K.

AU - Shih, Jerry J.

PY - 2001/6

Y1 - 2001/6

N2 - Vagus nerve stimulation (VNS) is a novel therapy used in patients with medically intractable epilepsy. We administered a Quality of Life in Epilepsy - 10 (QOLIE-10) questionnaire consisting of questions designed to assess the patients' rating of their memory, level of physical and mental well-being, energy, depression, worries about seizures and work, social limitations, and overall quality of life on VNS treatment. The questionnaire was administered before and at 1-3 weeks, 5-7 weeks, 3 months, 6 months, and 9-12 months after the initiation of VNS in 17 patients. QOLIE-10 scores were significantly better after the initiation of the therapy as compared with baseline (P < 0.01). There was no correlation between the improvement in QOLIE-10 scores and the reduction in seizure frequency, decreased severity of seizures, or increased level of energy/alertness. We conclude that VNS therapy is associated with a significant improvement in subjective quality of life.

AB - Vagus nerve stimulation (VNS) is a novel therapy used in patients with medically intractable epilepsy. We administered a Quality of Life in Epilepsy - 10 (QOLIE-10) questionnaire consisting of questions designed to assess the patients' rating of their memory, level of physical and mental well-being, energy, depression, worries about seizures and work, social limitations, and overall quality of life on VNS treatment. The questionnaire was administered before and at 1-3 weeks, 5-7 weeks, 3 months, 6 months, and 9-12 months after the initiation of VNS in 17 patients. QOLIE-10 scores were significantly better after the initiation of the therapy as compared with baseline (P < 0.01). There was no correlation between the improvement in QOLIE-10 scores and the reduction in seizure frequency, decreased severity of seizures, or increased level of energy/alertness. We conclude that VNS therapy is associated with a significant improvement in subjective quality of life.

KW - Vagus nerve stimulation; quality of life; refractory epilepsy

UR - http://www.scopus.com/inward/record.url?scp=0000919344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000919344&partnerID=8YFLogxK

U2 - 10.1006/ebeh.2001.0173

DO - 10.1006/ebeh.2001.0173

M3 - Article

AN - SCOPUS:0000919344

VL - 2

SP - 284

EP - 287

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 3

ER -